RedHill Biopharma inks $1.8 million Middle East licensing deal for Talicia
RedHill will receive $500,000 in guaranteed payments, including a $250,000 upfront payment and $250,000 in fixed payments due within 18 months
RedHill will receive $500,000 in guaranteed payments, including a $250,000 upfront payment and $250,000 in fixed payments due within 18 months
FineCross M3 empowers physicians to perform safer PCI procedures, helping improve outcomes in patients with challenging coronary anatomies
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
New study presents a human-relevant stress model for assessing potential therapeutics
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal phase III IMforte study
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
Subscribe To Our Newsletter & Stay Updated